Efficacy and safety of combining pentoxifylline with angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in diabetic nephropathy: a meta-analysis

被引：0
|
作者：
Mao-Lu Tian
Yan Shen
Zhao-Lin Sun
Yan Zha
机构：
[1] Guizhou Provincial People’s Hospital,Institute of Nephritic and Urinary Disease, Department of Nephrology
[2] Guizhou Provincial People’s Hospital,Institute of Nephritic and Urinary Disease, Department of Urology
来源：
International Urology and Nephrology | 2015年 / 47卷
关键词：
Diabetic nephropathy; Pentoxifylline; Angiotensin-converting enzyme inhibitors; Angiotensin receptor blockers; Randomized controlled trails;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：815 / 822
页数：7
相关论文
共 50 条
  • [31] Olmesartan is an angiotensin II receptor blocker with an inhibitory effect of angiotensin-converting enzyme
    Agata, Jun
    Ura, Nobuyuki
    Yoshida, Hideaki
    Shinshi, Yasuyuki
    Sasaki, Haruki
    Hyakkoku, Masaya
    Taniguchi, Shinya
    Shimamoto, Kazuaki
    JOURNAL OF HYPERTENSION, 2006, 24 : 208 - 208
  • [32] Olmesartan Is an Angiotensin II Receptor Blocker with an Inhibitory Effect on Angiotensin-Converting Enzyme
    Jun Agata
    Nobuyuki Ura
    Hideaki Yoshida
    Yasuyuki Shinshi
    Haruki Sasaki
    Masaya Hyakkoku
    Shinya Taniguchi
    Kazuaki Shimamoto
    Hypertension Research, 2006, 29 : 865 - 874
  • [33] Olmesartan is an angiotensin II receptor blocker with an inhibitory effect on angiotensin-converting enzyme
    Agata, Jun
    Ura, Nobuyuki
    Yoshida, Hideaki
    Shinshi, Yasuyuki
    Sasaki, Haruki
    Hyakkoku, Masaya
    Taniguchi, Shinya
    Shimamoto, Kazuaki
    HYPERTENSION RESEARCH, 2006, 29 (11) : 865 - 874
  • [34] Clinical evidence from ONTARGET: the value of an angiotensin II receptor blocker and an angiotensin-converting enzyme inhibitor
    Sleight, Peter
    JOURNAL OF HYPERTENSION, 2009, 27 : S23 - S29
  • [35] Efficacy and Safety of Angiotensin Receptor-Neprilysin Inhibitor Versus Angiotensin Converting Enzyme Inhibitor or Angiotensin Receptor Blocker in Acute Myocardial Infarction Patients: A Meta-Analysis of Randomized Controlled Trials
    Ananta, Muammar Emir
    Ivan, Ignatius
    Wijaya, Alya Darin
    Albab, Chabib Fachry
    Danny, Siska
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (16) : S23 - S24
  • [36] Reporting on sex-based analysis in clinical trials of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker efficacy
    Rabi, D. M.
    Khan, N.
    Vallee, M.
    Hladunewich, M. A.
    Tobe, S. W.
    Pilote, L.
    CANADIAN JOURNAL OF CARDIOLOGY, 2008, 24 (06) : 491 - 496
  • [37] Efficacy of combined angiotensin II receptor blocker with tripterygium glycosides on diabetic nephropathy A protocol for meta-analysis
    Ma, Chang-e
    Yu, Pei
    Wei, Wei
    Chen, Xiao-qin
    MEDICINE, 2021, 100 (22) : E25991
  • [38] Combination therapy with an ACE inhibitor and an angiotensin receptor blocker for diabetic nephropathy: a meta-analysis
    Jennings, D. L.
    Kalus, J. S.
    Coleman, C. I.
    Manierski, C.
    Yee, J.
    DIABETIC MEDICINE, 2007, 24 (05) : 486 - 493
  • [39] Treatment for diabetic nephropathy: Angiotensin receptor blockers preferred to angiotensin-converting enzyme inhibitors
    Harman-Boehm, I
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2004, 6 (05): : 296 - 298
  • [40] Combination of half doses of angiotensin type 1 receptor antagonist and angiotensin-converting enzyme inhibitor in diabetic nephropathy
    Fujisawa, T
    Ikegami, H
    Ono, M
    Nishino, M
    Noso, S
    Kawabata, Y
    Ogihara, T
    AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (01) : 13 - 17
12345